Equity Research Associate – Emerging Immunology

Leerink Partners•Boston, NY

6d•Onsite

About The Position

This individual will work closely with senior equity research professionals to develop expertise in emerging immunology, covering companies developing novel therapies in autoimmune disease, inflammation, and related areas. The associate role spans fundamental analysis, scientific diligence, and client-facing research, offering a unique position at the intersection of science and finance. The ideal candidate will possess a strong sense of intellectual curiosity and independent thought, passion for investing as well as the ability to thrive in a fast-moving, deadline driven environment.

Requirements

Academic background strongly preferred: MD, PhD, or PharmD
Direct exposure to immunology, inflammation, autoimmune disease, or related therapeutic areas is a strong plus
Excellent written and verbal communication skills
Ability to search, understand and distill complex scientific and medical publications into succinct and actionable insights for biotech investors
Familiarity with the biotechnology and pharmaceutical industries including clinical development, regulatory affairs, business development and commercialization
Strong quantitative, financial modeling, forecasting and Excel skills
Comfort interpreting clinical trial statistics, including statistical powering, trial design strategies (e.g., ITT versus PP), and hazard ratios

Responsibilities

Formulate in-depth investment recommendations based on fundamental analysis, valuation and risk assessment across the emerging immunology landscape
Collect and rigorously analyze data related to therapeutics and various diseases, including scientific papers, clinical data, and KOL perspectives
Design and execute primary market research, including market surveys and expert interviews, synthesizing findings into differentiated investment insights
Build, maintain, and refine financial models, including DCFs, probability adjusted revenue forecasts, and scenario analyses
Author research reports, initiation notes, and company updates for distribution to Leerink Partners’ institutional clients and sales force
Engage directly with institutional clients and internal stakeholders to communicate investment views and respond to market-driven inquiries
Monitor news, data releases, and regulatory updates across the coverage universe, providing timely commentary to clients and the sales force
Support senior equity analysts at medical and industry conferences